Alder Biopharmaceuticals IPO Research Information

Alder Biopharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Alder Biopharmaceuticals, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Alder Biopharmaceuticals	ALDR - NASDAQ	$13.00-$15.00	$10.00	$10.35	7.15 million	5/8/2014
Underwriter(s): Credit Suisse, Leerink Partners.
Co-Manager(s): Wells Fargo Securities, Sanford C. Bernstein
Industry: Health Care
Filing(s): Filed 2014-03-19 Terms Added 2014-04-30

Alder Biopharmaceuticals Quote & Chart - Click for current quote - ALDR

About Alder Biopharmaceuticals (adapted from Alder Biopharmaceuticals prospectus):
They are a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize therapeutic antibodies with the potential to meaningfully transform current treatment paradigms.

This description is adapted from Alder Biopharmaceuticals prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Alder Biopharmaceuticals "ALDR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.